Circulation:验血就能诊断出心肌炎?

2022-11-29 中国医学论坛报今日循环 中国医学论坛报今日循环 发表于上海

心肌炎是以心肌发生局限性或弥漫性炎性病变为主要表现的一种疾病,其症状包括体温升高、疲劳、胸痛和呼吸急促,很容易被误诊为其他疾病。

心肌炎是以心肌发生局限性或弥漫性炎性病变为主要表现的一种疾病,其症状包括体温升高、疲劳、胸痛和呼吸急促,很容易被误诊为其他疾病。

心肌炎的诊断比较困难,目前用于诊断的黄金标准方法为心脏活检。这是一种价格昂贵、具有侵入性、比较危险的操作,而且有时候仍会存在漏诊的情况。

近期,英国伦敦玛丽女王大学的研究人员在《循环》杂志上发表重要研究成果。

研究结论

该研究发现了一种可用于诊断心肌炎的血液生物标志物——表达cMet分子的T细胞,通过血常规检测就能发现这种致命且难以诊断的心肌炎,价格不到50英镑,数小时内就能获得检测结果。研究人员表示,这种诊断技术有望一年内投入使用。

图片

在这项研究中,研究人员比较了几组患者的血液样本,其中包括34例最终被诊断为心肌炎的患者。

结果显示,与其他组(包括心脏病发作的患者及正常人群)相比,心肌炎患者血液中表达cMet的T细胞水平显著增加。

研究人员希望这一发现能够改善心肌炎的诊断,帮助患者更早地接受治疗,从而降低并发症的发生和死亡风险。

英国心脏基金会医学主任Nilesh Samani教授表示:“这种血液测试可能会彻底改变诊断心肌炎的方式,使医生能够在更早的阶段介入治疗,还能降低目前使用心脏活检的风险和需求。”

原始出处

Circulation c-met-expressing memory T Cells Define Cardiac Autoimmunity.Circulation.2022

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2103448, encodeId=ae7e2103448b8, content=`丷⺍⺍单单单纟乍纯, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnHtEgiaNiaUeanPblicnQPORicamAtCLvWmTKDxxWwF3J99R5MdjnGACh16icoScCeRrNQOibvvPqiaDrA/132, createdBy=83465314460, createdName=八骏奔腾, createdTime=Wed Nov 30 08:56:50 CST 2022, time=2022-11-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2103437, encodeId=5790210343ea2, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Nov 30 08:17:58 CST 2022, time=2022-11-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103417, encodeId=0143210341e04, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Nov 29 23:52:12 CST 2022, time=2022-11-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2103431, encodeId=bd8d2103431b9, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Wed Nov 30 06:40:43 CST 2022, time=2022-11-30, status=1, ipAttribution=吉林省)]
    2022-11-30 八骏奔腾 来自山东省

    `丷⺍⺍单单单纟乍纯

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2103448, encodeId=ae7e2103448b8, content=`丷⺍⺍单单单纟乍纯, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnHtEgiaNiaUeanPblicnQPORicamAtCLvWmTKDxxWwF3J99R5MdjnGACh16icoScCeRrNQOibvvPqiaDrA/132, createdBy=83465314460, createdName=八骏奔腾, createdTime=Wed Nov 30 08:56:50 CST 2022, time=2022-11-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2103437, encodeId=5790210343ea2, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Nov 30 08:17:58 CST 2022, time=2022-11-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103417, encodeId=0143210341e04, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Nov 29 23:52:12 CST 2022, time=2022-11-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2103431, encodeId=bd8d2103431b9, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Wed Nov 30 06:40:43 CST 2022, time=2022-11-30, status=1, ipAttribution=吉林省)]
    2022-11-30 xulv123 来自河南省

    认真学习~~

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2103448, encodeId=ae7e2103448b8, content=`丷⺍⺍单单单纟乍纯, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnHtEgiaNiaUeanPblicnQPORicamAtCLvWmTKDxxWwF3J99R5MdjnGACh16icoScCeRrNQOibvvPqiaDrA/132, createdBy=83465314460, createdName=八骏奔腾, createdTime=Wed Nov 30 08:56:50 CST 2022, time=2022-11-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2103437, encodeId=5790210343ea2, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Nov 30 08:17:58 CST 2022, time=2022-11-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103417, encodeId=0143210341e04, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Nov 29 23:52:12 CST 2022, time=2022-11-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2103431, encodeId=bd8d2103431b9, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Wed Nov 30 06:40:43 CST 2022, time=2022-11-30, status=1, ipAttribution=吉林省)]
    2022-11-29 1209e435m98(暂无昵称) 来自浙江省

    学习了,谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2103448, encodeId=ae7e2103448b8, content=`丷⺍⺍单单单纟乍纯, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnHtEgiaNiaUeanPblicnQPORicamAtCLvWmTKDxxWwF3J99R5MdjnGACh16icoScCeRrNQOibvvPqiaDrA/132, createdBy=83465314460, createdName=八骏奔腾, createdTime=Wed Nov 30 08:56:50 CST 2022, time=2022-11-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2103437, encodeId=5790210343ea2, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Nov 30 08:17:58 CST 2022, time=2022-11-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103417, encodeId=0143210341e04, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Nov 29 23:52:12 CST 2022, time=2022-11-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2103431, encodeId=bd8d2103431b9, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Wed Nov 30 06:40:43 CST 2022, time=2022-11-30, status=1, ipAttribution=吉林省)]
    2022-11-30 仁术2021 来自吉林省

    不错,学习了。

    0

相关资讯

European Radiology:CMR特征对ICI相关性心肌炎的预后价值

作为非侵入性多参数影像学成像,心血管磁共振成像(CMR)可以通过定量和定性方法评估包括心肌水肿和纤维化在内的组织特征。

Radiology:免疫检查点抑制剂诱发心肌炎的心脏MRI特征及预后价值

根据更新的2018-LL标准,心脏MRI现在被认为是诊断非ICI诱发的心肌炎的最佳无创成像方式。

用免疫检查点抑制剂,要提防心肌炎!研究

而免疫检查点抑制剂所致心肌炎一旦发生,死亡率可达36.96%~50.00%。

Radiology:COVID-19疫苗相关性心肌炎的MRI心肌损伤模式

免疫接种后的心肌炎是一个罕见的事件,最近由于少数患者在注射基于信使RNA(mRNA)的COVID-19疫苗后出现心肌损伤的报道而受到越来越多的关注。

Circulation:接种COVID-19疫苗和SARS-CoV-2感染后心肌炎的风险

感染SARS-CoV-2后发生心肌炎的风险高于接种COVID-19疫苗后发生心肌炎的风险,连续注射包括加强剂量BNT162b2mRNA疫苗后发生心肌炎的风险仍不高。